Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,1554320,Bmd1,Bone mineral density QTL 1,12.2,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),1,254393,86904217,Rat,n/a,region,qtl 1000,1578650,Bmd6,Bone mineral density QTL 6,12.2,,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),1,254393,43579402,Rat,n/a,region,qtl 1000,2313090,Bmd69,Bone mineral density QTL 69,4.4,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,1,34993530,Rat,n/a,region,qtl 1000,1578651,Bmd7,Bone mineral density QTL 7,14.2,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),1,254393,43579402,Rat,n/a,region,qtl 1000,2313092,Bmd72,Bone mineral density QTL 72,2.5,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313062,Bmd73,Bone mineral density QTL 73,3.9,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,11314489,83657083,Rat,n/a,region,qtl 1000,7421626,Bp360,Blood pressure QTL 360,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,4578693,49578693,Rat,n/a,region,qtl 1000,5684998,Bss101,Bone structure and strength QTL 101,3.6,,tibia strength trait (VT:1000284),tibia ultimate force (CMO:0001734),1,16143143,49547474,Rat,n/a,region,qtl 1000,5684999,Bss102,Bone structure and strength QTL 102,5.5,0.00000072,tibia strength trait (VT:1000284),tibia stiffness (CMO:0001735),1,16143143,49547474,Rat,n/a,region,qtl 1000,2313053,Bss51,Bone structure and strength QTL 51,3.8,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,1,34993530,Rat,n/a,region,qtl 1000,2313070,Bss52,Bone structure and strength QTL 52,4.4,0.0001,body length (VT:0001256),body length (CMO:0000013),1,1,34993530,Rat,n/a,region,qtl 1000,2313075,Bss66,Bone structure and strength QTL 66,3.4,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313065,Bss67,Bone structure and strength QTL 67,3.1,0.0001,tibia area (VT:1000281),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313069,Bss68,Bone structure and strength QTL 68,2.9,0.0001,tibia size trait (VT:0100001),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313077,Bss69,Bone structure and strength QTL 69,3.5,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313097,Bss70,Bone structure and strength QTL 70,3.5,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,1578669,Bss9,Bone structure and strength QTL 9,6.3,,femur morphology trait (VT:0000559),bone trabecular cross-sectional area (CMO:0002311),1,254393,43579402,Rat,n/a,region,qtl 1000,1354647,Despr8,Despair related QTL 8,,0.0000341,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),1,1,24368159,Rat,n/a,region,qtl 1000,4889451,Eae29,Experimental allergic encephalomyelitis QTL 29,5.51,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),1,5655772,85706974,Rat,n/a,region,qtl 1000,2317755,Glom22,Glomerulus QTL 22,3.8,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),1,11314658,34993348,Rat,n/a,region,qtl 1000,631688,Hcas2,Hepatocarcinoma susceptibility QTL 2,3,0.0001,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,5655769,122614963,Rat,n/a,region,qtl 1000,1300167,Hrtrt2,Heart rate QTL 2,4.35,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),1,11314489,75844121,Rat,n/a,region,qtl 1000,1600360,Mcs16,Mammary carcinoma susceptibility QTL 16,2.4,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),1,1868045,43724576,Rat,n/a,region,qtl 1000,2298546,Neuinf4,Neuroinflammation QTL 4,5.1,,nervous system integrity trait (VT:0010566),spinal cord RT1-B protein level (CMO:0002132),1,1,28468970,Rat,n/a,region,qtl 1000,2302038,Pia31,Pristane induced arthritis QTL 31,5.5,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin M-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002111),1,13629251,58629251,Rat,n/a,region,qtl 1000,738020,Pia8,Pristane induced arthritis QTL 8,4.7,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),1,1,64407321,Rat,n/a,region,qtl 1000,631508,Sald1,Serum aldosterone level QTL 1,3.7,,blood aldosterone amount (VT:0005346),serum aldosterone level (CMO:0000487),1,12493439,57493439,Rat,n/a,region,qtl 1000,70179,Xhs2,X-ray hypersensitivity QTL 2,3.2,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),1,16033078,20130904,Rat,n/a,region,qtl